Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men.

Esposito R, Spaziano G, Giannattasio D, Ferrigno F, Liparulo A, Rossi A, Roviezzo F, Sessa M, Falciani M, Berrino L, Polverino M, Polverino F, D'Agostino B.

Front Pharmacol. 2019 Sep 24;10:1094. doi: 10.3389/fphar.2019.01094. eCollection 2019.

2.

The European clinical trials regulation (No 536/2014): changes and challenges.

Scavone C, di Mauro G, Pietropaolo M, Alfano R, Berrino L, Rossi F, Tomino C, Capuano A.

Expert Rev Clin Pharmacol. 2019 Oct 21:1-6. doi: 10.1080/17512433.2019.1680282. [Epub ahead of print]

PMID:
31608706
3.

Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Mascolo A, Urbanek K, De Angelis A, Sessa M, Scavone C, Berrino L, Rosano GMC, Capuano A, Rossi F.

Heart Fail Rev. 2019 Aug 2. doi: 10.1007/s10741-019-09837-7. [Epub ahead of print] Review.

PMID:
31375968
4.

Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib".

Gorini S, De Angelis A, Berrino L, Malara N, Rosano G, Ferraro E.

Oxid Med Cell Longev. 2019 Jun 26;2019:9601435. doi: 10.1155/2019/9601435. eCollection 2019.

5.

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs.

Scavone C, di Mauro G, Mascolo A, Berrino L, Rossi F, Capuano A.

Front Pharmacol. 2019 Feb 13;10:111. doi: 10.3389/fphar.2019.00111. eCollection 2019. Review.

6.

Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension.

Cappetta D, Ciuffreda LP, Cozzolino A, Esposito G, Scavone C, Sapio L, Naviglio S, D'Amario D, Crea F, Rossi F, Berrino L, De Angelis A, Urbanek K.

Oxid Med Cell Longev. 2019 Jan 10;2019:8912768. doi: 10.1155/2019/8912768. eCollection 2019.

7.

Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc.

Costantino S, Paneni F, Mitchell K, Mohammed SA, Hussain S, Gkolfos C, Berrino L, Volpe M, Schwarzwald C, L├╝scher TF, Cosentino F.

Int J Cardiol. 2018 Oct 1;268:179-186. doi: 10.1016/j.ijcard.2018.04.082. Epub 2018 Jun 30.

PMID:
30047409
8.

Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article.

Mascolo A, Berrino PM, Gareri P, Castagna A, Capuano A, Manzo C, Berrino L.

Inflammopharmacology. 2018 Oct;26(5):1141-1149. doi: 10.1007/s10787-018-0498-5. Epub 2018 Jun 9. Review.

PMID:
29948492
9.

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib.

Gorini S, De Angelis A, Berrino L, Malara N, Rosano G, Ferraro E.

Oxid Med Cell Longev. 2018 Mar 18;2018:7582730. doi: 10.1155/2018/7582730. eCollection 2018. Review. Erratum in: Oxid Med Cell Longev. 2019 Jun 26;2019:9601435.

10.

Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema.

Cappetta D, De Angelis A, Spaziano G, Tartaglione G, Piegari E, Esposito G, Ciuffreda LP, Liparulo A, Sgambato M, Russo TP, Rossi F, Berrino L, Urbanek K, D'Agostino B.

Stem Cells Int. 2018 Mar 14;2018:9492038. doi: 10.1155/2018/9492038. eCollection 2018.

11.

Chronic exposure to low dose of bisphenol A impacts on the first round of spermatogenesis via SIRT1 modulation.

Chianese R, Viggiano A, Urbanek K, Cappetta D, Troisi J, Scafuro M, Guida M, Esposito G, Ciuffreda LP, Rossi F, Berrino L, Fasano S, Pierantoni R, De Angelis A, Meccariello R.

Sci Rep. 2018 Feb 13;8(1):2961. doi: 10.1038/s41598-018-21076-8.

12.

Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.

Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, Rossi F, Berrino L, Naviglio S, Urbanek K.

Oxid Med Cell Longev. 2017;2017:1521020. doi: 10.1155/2017/1521020. Epub 2017 Oct 18. Review.

13.

Strengths, weaknesses and future challenges of biosimilars' development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice.

Scavone C, Rafaniello C, Berrino L, Rossi F, Capuano A.

Pharmacol Res. 2017 Dec;126:138-142. doi: 10.1016/j.phrs.2017.11.002. Epub 2017 Nov 4. Review.

PMID:
29113760
14.

Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors.

Savi M, Frati C, Cavalli S, Graiani G, Galati S, Buschini A, Madeddu D, Falco A, Prezioso L, Mazzaschi G, Galaverna F, Lagrasta CAM, Corradini E, De Angelis A, Cappetta D, Berrino L, Aversa F, Quaini F, Urbanek K.

Pharmacol Res. 2018 Jan;127:15-25. doi: 10.1016/j.phrs.2017.09.020. Epub 2017 Sep 28.

PMID:
28964914
15.

Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study.

Scavone C, Sportiello L, Sullo MG, Ferrajolo C, Ruggiero R, Sessa M, Berrino PM, di Mauro G, Berrino L, Rossi F, Rafaniello C, Capuano A; BIO-Cam Group.

Front Pharmacol. 2017 Sep 6;8:607. doi: 10.3389/fphar.2017.00607. eCollection 2017.

16.

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer.

Morgillo F, Fasano M, Della Corte CM, Sasso FC, Papaccio F, Viscardi G, Esposito G, Di Liello R, Normanno N, Capuano A, Berrino L, Vicidomini G, Fiorelli A, Santini M, Ciardiello F.

ESMO Open. 2017 May 2;2(2):e000132. doi: 10.1136/esmoopen-2016-000132. eCollection 2017.

17.

Doxorubicin targets multiple players: A new view of an old problem.

Cappetta D, Rossi F, Piegari E, Quaini F, Berrino L, Urbanek K, De Angelis A.

Pharmacol Res. 2018 Jan;127:4-14. doi: 10.1016/j.phrs.2017.03.016. Epub 2017 Mar 20. Review.

PMID:
28336372
18.

Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction.

Cappetta D, Esposito G, Coppini R, Piegari E, Russo R, Ciuffreda LP, Rivellino A, Santini L, Rafaniello C, Scavone C, Rossi F, Berrino L, Urbanek K, De Angelis A.

Br J Pharmacol. 2017 Nov;174(21):3696-3712. doi: 10.1111/bph.13791. Epub 2017 May 16.

19.

Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes.

Cimmino G, Ciuffreda LP, Ciccarelli G, Calabr├▓ P, Ferraiolo FA, Rivellino A, De Palma R, Golino P, Rossi F, Cirillo P, Berrino L.

Front Cardiovasc Med. 2017 Feb 7;4:1. doi: 10.3389/fcvm.2017.00001. eCollection 2017.

20.

Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve.

Scavone C, Sportiello L, Berrino L, Rossi F, Capuano A.

Pharmacol Res. 2017 May;119:265-271. doi: 10.1016/j.phrs.2017.02.006. Epub 2017 Feb 16. No abstract available.

PMID:
28214611

Supplemental Content

Loading ...
Support Center